



SARS-CoV-2 productively infects human
gut enterocytes
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Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can cause coronavirus disease 2019
(COVID-19), an influenza-like disease that is primarily thought to infect the lungs with transmission
through the respiratory route. However, clinical evidence suggests that the intestine may present
another viral target organ. Indeed, the SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) is
highly expressed on differentiated enterocytes. In human small intestinal organoids (hSIOs), enterocytes
were readily infected by SARS-CoV and SARS-CoV-2, as demonstrated by confocal and electron
microscopy. Enterocytes produced infectious viral particles, whereas messenger RNA expression
analysis of hSIOs revealed induction of a generic viral response program. Therefore, the intestinal
epithelium supports SARS-CoV-2 replication, and hSIOs serve as an experimental model for coronavirus
infection and biology.
S
evere acute respiratory syndrome (SARS),
caused by the coronavirus SARS-CoV,
emerged in 2003 (1). In late 2019, a
novel transmissible coronavirus, SARS-
coronavirus 2 (SARS-CoV-2), was noted
to cause an influenza-like disease ranging from
mild respiratory symptoms to severe lung in-
jury,multiorgan failure, and death (2–4). SARS-
CoVandSARS-CoV-2belong to theSarbecovirus
subgenus of the genus Betacoronavirus in the
family Coronaviridae (5–7). The SARS-CoV
receptor is angiotensin-converting enzyme 2
(ACE2) (8, 9). The spike proteins of both viruses
bind to ACE2, whereas soluble ACE2 blocks in-
fection by SARS-CoV and SARS-CoV-2 (10–13).
Transmission of SARS-CoV-2 is thought to oc-
cur through respiratory droplets and fomites.
The virus can be detected in upper respiratory
tract samples, implicating the nasopharynx as
a site of replication. In human lung, ACE2 is
expressed mainly in alveolar epithelial type II
cells and ciliated cells (14–16). However, the
highest expression of ACE2 in the human body
occurs in the brush border of intestinal entero-
cytes (14, 17). Even though respiratory symp-
toms dominate the clinical presentation of
COVID-19, gastrointestinal symptoms are ob-
served in a subset of patients (18, 19). More-
over, viral RNA can be found in rectal swabs
even after nasopharyngeal testing has turned
negative, implying gastrointestinal infection
and a fecal–oral transmission route (20–22).
SARS-CoV-2 infects airway and gut organoids
Organoids are three-dimensional (3D) struc-
tures that can be grown from adult stem cells
and recapitulate key aspects of the organ from
which those cells derive. Because SARS-CoV
and SARS-CoV-2 target the lung, we added
virus to organoid-derived human airway epi-
theliumcultured in 2Dandobserved that SARS-
CoV and SARS-CoV-2 readily infected differen-
tiated airway cultures. (Fig. 1A). Immunostain-
ing reveal that the viruses targeted ciliated cells
but not goblet cells (Fig. 1, B and C).
Human small intestinal organoids (hSIOs)
are established from primary gut epithelial
stem cells, can be expanded indefinitely in 3D
culture, and contain all proliferative and dif-
ferentiated cell types of the in vivo epithelium
(23). hSIOs have also allowed the first in vitro
culturing of norovirus (24). We exposed ileal
hSIOs grown under four different culture con-
ditions (EXP, DIF, DIF-BMP, and EEC) to
SARS-CoV and SARS-CoV-2 at a multiplicity
of infection of 1. hSIOs grown in Wnt high-
expansion (EXP) medium overwhelmingly
consisted of stem cells and enterocyte progen-
itors. Organoids grown in differentiation (DIF)
medium contained enterocytes, goblet cells,
and low numbers of enteroendocrine cells
(EECs). The addition of BMP2/4 to DIF me-
dium (DIF-BMPmedium) led to further mat-
uration (25). In the final condition (EEC), we
induced the expression of NeuroG3 from a
stably transfected vector with doxycycline to
raise EEC numbers (fig. S3D). Samples were
harvested at multiple time points after in-
fection and processed for the analyses shown
in Figs. 2 to 5. Both SARS-CoV and SARS-CoV-2
productively infected hSIOs, as assessed by
quantitative reverse transcription polymerase
chain reaction (qRT-PCR) for viral sequences
and by live virus titrations on VeroE6 cells (see
Fig. 2 for lysed organoids and fig. S1 for or-
ganoid supernatant). Infectious virus particles
and viral RNA increased for both viruses in all
conditions. Because EXP medium supported
virus replication (Fig. 2, A and E), enterocyte
progenitors appeared to be a primary viral
target. Differentiated organoids (grown in
DIF and DIF-BMPmedium) produced slightly
(nonstatistically significant) lower levels of
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Fig. 1. SARS-CoV and SARS-CoV-2 infect 2D human airway cultures. (A) Live virus titers can be
observed by virus titrations on VeroE6 cells of apical washes at 2, 24, 48, 72, and 96 h after infection with
SARS-CoV (blue) and SARS-CoV-2 (red). The dotted line indicates the lower limit of detection. Error bars
indicate SEM. N = 4. *P < 0.05, **P < 0.01, ***P < 0.001. (B and C) Immunofluorescent staining of SARS-
CoV-2–infected (B) and SARS-CoV–infected (C) differentiated airway cultures. Nucleoprotein (NP) stains
viral nucleocapsid (red), which colocalized with the ciliated cell marker AcTUB (green). Goblet cells are
identified by MUC5AC (blue). Nuclei are stained with TO-PRO3 (white). Scale bars, 20 mM. Top panels are
side views and bottom panels are top views.








infectious virus (Fig. 2 and fig. S1). In organ-
oids induced to generate EECs, virus yields
were similar to those in EXP medium (Fig. 2,
D and H). In differentiated hSIOs, SARS-CoV-2
titers remained stable at 60 hours after infec-
tion, whereas SARS-CoV titers dropped by
1 to 2 log (Fig. 2, B, C, F, and G). The latter
decline was not observed in infected hSIOs
grown in EXP medium. Culture supernatants
across culture conditions contained lower levels
of infectious virus compared with lysed hSIOs,
implying that virus was primarily secreted api-
cally (fig. S1, A toD). Despite this, viral RNAwas
detected readily in culture supernatants, cor-
relating with the infectious virus levels within
hSIOs (Fig. 2, E to H, and fig. S1, E to H).
ACE2 mRNA expression differed greatly be-
tween the four conditions. EXP-hSIOs expressed
300-fold less ACE2mRNA compared with DIF-
hSIOs when analyzed in bulk (fig. S2). BMP
treatment induced 6.5-fold up-regulation of
ACE2 mRNA compared with DIF treatment
alone. Because this did not yield infection rate
differences, the DIF-BMP condition was not
analyzed further.
SARS-CoV-2 infects enterocyte lineage cells
To determine the target cell type, we then per-
formed confocal analysis on hSIOs cultured
in EXP, DIF, or EEC conditions. We stained
for viral double-stranded RNA (dsRNA), viral
nucleocapsid protein, KI67 to visualize prolif-
erative cells, actin (using phalloidin) to visual-
ize enterocyte brush borders, and DNA (DAPI)
and cleaved caspase 3 to visualize apoptotic
cells. Generally, comparable rates of viral in-
fections were observed in the organoids grow-
ing in all three conditions. We typically noted
staining for viral components (white) in rare,
single cells at 24 hours. At 60 hours, the num-
ber of infected cells had substantially increased
(Fig. 3A). Infected cells invariably displayed
proliferative enterocyte progenitor phenotypes
(EXP; Fig. 3B, top) orApoA1+ enterocyte pheno-
types (DIF; Fig. 3B, bottom). SARS-CoV also
readily infected enterocyte lineage cells (fig.
S3, A and B), as was shown previously (26, 27).
Some infected enterocyte progenitors were
in mitosis (fig. S3C). Whereas EEC organoids
produced appreciable titers, we never observed
infection of chromogranin-A+ EECs (fig. S3,
D and E). We also did not observe infection
of goblet cells across culture conditions. At
60 hours, apoptosis became prominent in both
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Fig. 2. SARS-CoV and SARS-CoV-2 replicate
in hSIOs. (A to D) Live virus titers can be
observed by virus titrations on VeroE6 cells of
lysed organoids at 2, 24, 48, and 60 h after
infection with SARS-CoV (blue) and SARS-CoV-2
(red). Different medium compositions show
similar results. (E to H) qRT-PCR analysis
targeting the E gene of similar time points
and medium compositions as (A) to (D).
The dotted line indicates the lower limit of
detection. Error bars indicate SEM. N = 3.





















































































































































Fig. 3. SARS-CoV-2 infects proliferating cells and
enterocytes. (A) Immunofluorescent staining of SARS-
CoV-2–infected hSIOs. NP stains viral capsid. After
24 hours, single virus-infected cells are generally
observed in organoids. These small infection clusters
spread through the whole organoid after 60 hours.
(B) SARS-CoV-2 infects both postmitotic enterocytes
identified by Apolipoprotein A1 (APOA1) and dividing cells
that are KI67-positive. Infected cells are visualized by
dsRNA staining. Enterocytes are shown in differentiated
organoids and proliferating cells in expanding organoids.
Arrows point to APOA1-positive cells. (C) Immunofluorescent
staining of ACE2 in hSIOs in expansion and differentiation
condition. Scale bars, 50 mm.
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SARS-CoV– and SARS-CoV-2–infected entero-
cytes (fig. S5). ACE2 protein was readily re-
vealed as a bright and ubiquitous brush border
marker in hSIOs in DIF medium (Fig. 3C). In
hSIOs in EXP medium, ACE2 staining was
much lower, yet still apical, in occasional cells
in a subset of organoids that displayed amore
mature morphology (Fig. 3C). In immature
(cystic) organoids within the same cultures, the
ACE2 signal was below the detection threshold.
The percentages of infected organoids under
EXP and DIF conditions are given in fig. S4.
Figure S5 shows images and quantification of
apoptotic cells upon infection.
Ultrastructural analysis of the viral life cycle
in enterocytes
Unsupervised transmission electron micros-
copy (28) was performed on selected highly
infected samples. Figure 4 shows two hSIOs
selected from 42 hSIOs imaged at 60 hours
after SARS-CoV-2 infection. These differ in the
state of infection: Whereas the cellular orga-
nization within organoid 1 was still intact
(Fig. 4A, entire organoid; B to D, intermediate
magnification; E to K, high magnification),
many disintegrated cells can be seen in or-
ganoid 2 (Fig. 4, bottom; L, entire organoid; M
to O, intermediate magnification; P to R, high
magnification). Viral particles of 80 to 20 nm
occurred in the lumen of the organoid (Fig. 4I)
at the basolateral (Fig. 4J) and apical side (Fig.
4K) of enterocytes. Double-membrane vesicles,
which are the subcellular site of viral replica-
tion (29), are visualized in Fig. 4, E and P. The
nuclei in both organoids differed fromnuclei in
mock-infected organoids by having a slightly
rounder shape. Other differences were that the
nuclear contour index (30) was 4.0 ± 0.5 versus
4.3 ± 0.5 for the control set, and therewasmore
heterochromatin (Fig. 4N) and one or two dense
nucleoli in the center (Fig. 4O).
RNA expression changes in
infected enterocytes
We then performedmRNA-sequencing analysis
to determine gene expression changes induced
by SARS-CoV and SARS-CoV-2-infection of
hSIOs cultured continuously in EXP medium
and hSIOs cultured inDIFmedium. Infection
with SARS-CoV-2 elicited a broad signature
of cytokines and interferon (IFN)–stimulated
genes (ISGs) attributed to type I and III IFN
responses (Fig. 5A and tables S1 and S2), as
confirmed by gene ontology analysis (Fig. 5B).
An overlapping list of genes appeared in SARS-
CoV-2–infectedDIF organoids (fig. S6 and table
S3).mRNA-sequencing analysis confirmed dif-
ferentiation of DIF organoids into multiple in-
testinal lineages, including ACE2 up-regulation
(fig. S7). SARS-CoV also induced ISGs but to a
much lower level (table S4). Figure 5C shows
the regulation of SARS-CoV-2–induced genes
in SARS-CoV–infected organoids. This induc-
tion was similar to infections with other vi-
ruses such as norovirus (31), rotavirus (32), and
enteroviruses (33, 34). A recent study (35)
described an antiviral signature induced in
human cell lines after SARS-CoV-2 infection.
Whereas the ISG response was broader in
hSIOs, the induced gene sets were in close
agreement between the two datasets (fig. S8).
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Fig. 4. Transmission electron
microscopy analysis of SARS-
CoV-2–infected intestinal
organoids. (A to H) Overview
of an intact organoid (A) showing
the onset of virus infection
[(B) to (D)] at different stages
of the viral lifecycle, i.e., early
double membrane vesicles
(DMVs) [(E), asterisk], initial viral
production in the Golgi apparatus
[(F) and (G)], and complete
occupation of virus particles inside
the endomembrane system (H).
(I to K) Extracellular viruses are
observed in the lumen of the
organoid (I) and are found at the
basal side (J) and the apical
side (K) alongside the microvilli
(arrows). Scale bars, 10 mm (A),
2.5 mm [(B) to (D)], 250 nm
[(E), (F), and (H) to (K)] and
100 nm (G). (L to Q) Overview of
an organoid (L) showing severely
infected cells [(M) and (O)],
disintegrated cells (O), and
stressed cells as evident from
the atypical nucleoli (P). Intact
cells reveal DMV areas of
viral replication [(P), asterisks]
and infected Golgi apparatus (Q).
(R) Extracellular clusters of
viruses. Scale bars, 10 mm (L),
2.5 mm [(M) to (P)], and 250 nm
[(P) to (R)].
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One obvious similarity was the low expres-
sion of type I and III IFNs: We only noticed a
small induction of the type III IFN IFNL1 in
SARS-CoV-2–infected organoids. In SARS-CoV–
infected organoids, we did not observe any type
I or type III IFN induction. We confirmed
these findings by enzyme-linked immuno-
sorbent assay (ELISA) on the culture super-
natant and qRT-PCR on extracted RNA of the
hSIOs, which in addition to IFNL1, picked up
low levels of type I IFN IFNB1 in SARS-CoV-
2– but not in SARS-CoV–infected organoids
(fig. S9). The specific induction of IP-10/CXCL10
and ISG15 by SARS-CoV-2 was also confirmed
by ELISA and qRT-PCR, respectively (fig. S10).
As in a previous study (35), a few cytokine genes
were induced by both viruses, albeit to modest
levels. For a comparison with (35), see fig. S11.
Altogether, these data indicate that SARS-
CoV-2 induces a stronger IFN response than
SARS-CoV in hSIOs.
Finally, the infection was repeated in a sec-
ond experiment in the same ileal hSIO line
and analyzed after 72 hours. Analysis involved
viral titration (fig. S12), confocal imaging (fig.
S13), and mRNA sequencing (fig. S14). This ex-
periment essentially confirmed the observa-
tions presented above. A limited, qualitative
experiment applying confocal analysis dem-
onstrated the infectability of two other lines
available in the laboratory (one ileal and one
duodenal) from independent donors (fig. S13).
This study shows that SARS-CoV and SARS-
CoV-2 infect enterocyte lineage cells in an
hSIO model. We observed similar infection
rates of enterocyte precursors and enterocytes,
whereas ACE2 expression increased ~1000-fold
upon differentiation at the mRNA level (fig.
S2). This suggests that low levels of ACE2may
be sufficient for viral entry.
SARS-CoV-2 is the third highly pathogenic
coronavirus (after SARS-CoV and MERS-CoV)
to jump to humans within <20 years, suggest-
ing that new zoonotic coronavirus spillovers
are likely to occur in the future. Despite this,
limited information is available on corona-
virus pathogenesis and transmission, in part
because of the lack of in vitro cell models that
accurately model host tissues. Very recently, it
was shown that human induced pluripotent
stem cells differentiated toward a kidney fate
supported replication of SARS-CoV-2 (13). Our
data suggest that human organoids represent
faithful experimental models with which to
study the biology of coronaviruses.
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Fig. 5. Transcriptomic analy-
sis of SARS-CoV-2–infected
intestinal organoids.
(A) Heatmaps depicting the
25 most significantly enriched
genes upon SARS-CoV-2
infection in expanding intesti-
nal organoids. (B) Colored
bar represents the Z-score of
log2-transformed values.
Shown is the gene ontology
term enrichment analysis
for biological processes of
the 50 most significantly
up-regulated genes upon
SARS-CoV-2 infection in intes-
tinal organoids. (C) Heatmaps
depicting the genes from
(A) in SARS-CoV–infected
expanding organoids. Colored
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